SFRP4 and diabetes mellitus: These clinical results were also demonstrated by later studies [13, 14], which found that SFRP4 levels were significantly increased in impaired glucose tolerance patients and patients with different types of diabetes including type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of the adult (LADA).